Abstract:e13020 Background: Gastric carcinoma is one of the most common malignancies in east asian. Previous studies demonstrated around 10% of patients with gastric cancer were found to have pathogenic germline variants. While, predisposition genes of gastric cancer in Chinese patients are still largely unknown. Thus, we aim to delineate prevalence of deleterious germline mutations in Chinese gastric patients with hereditary high-risk familial cancer history. We also aim to analyze clinical relevance of deleterious germline mutations. Methods: Forty index cases were recruited from 7 institutions in China. DNA samples extracted from blood specimens were captured using a 171-cancer predisposition gene panel and then sequenced by MGI-SEQ 2000 platform. Germline variants were determined to be deleterious according to the ACMG 2015 guidelines. Pathogenic and Likely pathogenic germline variants were further validated by Sanger sequencing. Results: 12 of 40 (30%) probands had 13 pathogenic/likely pathogenic germline variants involving 11 different genes: CHEK2 (n = 2), SPINK1 (n = 2), BLM (n = 1), CDH1(n = 1), EXT2 (n = 1), MLH1 (n = 1), MSH2(n = 1), MUTYH (n = 1), PALB2 (n = 1), NF1 (n = 1), ERCC2 (n = 1). For patients with multiple primary cancers, pathogenic germline alterations were exclusively presented (5 out of 12) (P=0.003). Besides,27 germline variants (like EPCAM, RAD54B, FANCD2, FANCA) with uncertain significance in 15 patients were predicated to be deleterious via in silico predictors. Conclusions: This multi-institutional study identified 30% (12/40) of Chinese gastric cancer patients with family history to have deleterious germline alterations. And potential deleterious variants were also identified. Our data illustrates a significantly distinguished spectrum of germline variants compared with Caucasian ones. This may indicate unique carcinogenesis of gastric cancer in Chinese patients. Since patients with pathogenic or likely pathogenic germline variants have dismal clinical outcome and higher rate of multi-cancer occurrence, genetic counseling of gastric cancer should be considered for individuals with family history at their early age.

Genetic Factors Associated with Intestinal Metaplasia in a High Risk Singapore-Chinese Population: a Cohort Study.

Severity of Gastric Intestinal Metaplasia Predicts the Risk of Gastric Cancer: a Prospective Multicentre Cohort Study (GCEP).

Spatiotemporal genomic profiling of intestinal metaplasia reveals clonal dynamics of gastric cancer progression

Genomic and Epigenomic Profiling of High-Risk Intestinal Metaplasia Reveals Molecular Determinants of Progression to Gastric Cancer

H-Pylori Genotypes and Cytokine Gene Polymorphisms Influence the Development of Gastric Intestinal Metaplasia in A Chinese Population

Genetic Polymorphisms Of Cyp2e1, Gstt1, Gstp1, Gstm1, Aldh2, And Odc And The Risk Of Advanced Precancerous Gastric Lesions In A Chinese Population

Quantitative assessment of the association between glutathione S-transferase M1 polymorphism and the risk of developing nasopharyngeal cancer

A Multicenter Study Assessing the Prevalence of Germline Genetic Alterations in Chinese Gastric-Cancer Patients

Association of genetic polymorphisms of interleukins with gastric cancer and precancerous gastric lesions in a high-risk Chinese population

IDDF2022-ABS-0213 Gastric Intestinal Metaplasia May Attenuate Reflux Symptoms – Analysis of a Large Observational Prospective Cohort

Inflammatory Cytokine Gene Polymorphisms Increase the Risk of Atrophic Gastritis and Intestinal Metaplasia

Risk factors associated with the development of intestinal metaplasia in first-degree relatives of gastric cancer patients.

S2334 Risk Factor Prevalence in Gastric Intestinal Metaplasia in a Diverse Urban Population

Association between PPARγ, PPARGC1A, and PPARGC1B genetic variants and susceptibility of gastric cancer in an Eastern Chinese population

Factors associated with the progression of gastric intestinal metaplasia: a multicenter, prospective cohort study

Role of Polymorphisms of the IGF2 and IGFBP3 Genes and Risk of Gastric Carcinoma in China.

Glutathione S-transferase M1 gene polymorphism and gastric cancer risk: an updated analysis

A Multi-Institutional Investigation Assessing Prevalence of Germline Genetic Alterations in Chinese Patients with Gastric Carcinoma.

Genome-wide DNA methylation and transcriptomic patterns of precancerous gastric cardia lesions

P53 Polymorphism And P21(Waf1/Cip1) Haplotype In The Intestinal Gastric Cancer And The Precancerous Lesions

Genetic polymorphism of the phospholipase C epsilon 1 gene and risk of gastric cancer.